(ALLO) Allogene Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Allogene Therapeutics | (ALLO) share price targets
Complete technical analysis of Allogene Therapeutics (ALLO) by charts plus indicators, forecast predictions and share price targets for Allogene Therapeutics (ALLO)
Allogene Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-23 View latest technical analysis
10 day averaged volume of Allogene Therapeutics is 1496005
| Date | Daily Closing Price | Open | High | Low | Volume |
| 23 Fri Aug 2024 | 2.61 | 2.62 | 2.72 | 2.56 | 1.398 times |
| 22 Thu Aug 2024 | 2.59 | 2.74 | 2.75 | 2.55 | 1.033 times |
| 21 Wed Aug 2024 | 2.74 | 2.65 | 2.88 | 2.65 | 1.24 times |
| 20 Tue Aug 2024 | 2.64 | 2.62 | 2.75 | 2.53 | 1.109 times |
| 19 Mon Aug 2024 | 2.56 | 2.28 | 2.59 | 2.27 | 0.887 times |
| 16 Fri Aug 2024 | 2.29 | 2.30 | 2.32 | 2.22 | 0.754 times |
| 15 Thu Aug 2024 | 2.30 | 2.30 | 2.41 | 2.24 | 1.075 times |
| 14 Wed Aug 2024 | 2.25 | 2.39 | 2.40 | 2.22 | 0.912 times |
| 13 Tue Aug 2024 | 2.35 | 2.39 | 2.43 | 2.29 | 0.86 times |
| 12 Mon Aug 2024 | 2.36 | 2.33 | 2.37 | 2.23 | 0.872 times |
My analysis of stock is bullish for shortterm, and stock might move up till 2.8 or till 3. Use a stoploss of 2.55 and if this stock hits its stoploss, then it can fall down till 2.33
Share price targets for Allogene Therapeutics (ALLO)
| Target Type | Value |
| Downside Target | 2.01 |
| Downside Target | 2.18 |
| Downside Target | 2.43 |
| Upside Target | 2.68 |
| Upside Target | 2.73 |
| Upside Target | 2.88 |
| Upside Target | 2.97 |
| Upside Target | 3.12 |
| Upside Target | 3.65 |
| Upside Target | 3.67 |
| Upside Target | 4.45 |
Intraday share price targets for Allogene Therapeutics (ALLO)
| Target Type | Value |
| Downside Intraday Target | 2.29 |
| Downside Intraday Target | 1.98 |
| Upside Intraday Target | 2.9 |
| Upside Intraday Target | 3.2 |
| Downside Intraday Target | 2.59 |
Weekly technical analysis of Allogene Therapeutics (ALLO)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 23 Fri Aug 2024 | 2.61 | 2.28 | 2.88 | 2.27 | 1.267 times |
| 16 Fri Aug 2024 | 2.29 | 2.33 | 2.43 | 2.22 | 0.61 times |
| 09 Fri Aug 2024 | 2.32 | 2.40 | 2.71 | 2.25 | 1.382 times |
| 02 Fri Aug 2024 | 2.57 | 2.99 | 3.12 | 2.47 | 0.858 times |
| 26 Fri Jul 2024 | 3.00 | 2.85 | 3.12 | 2.73 | 0.392 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Allogene Therapeutics (ALLO)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 23 Fri Aug 2024 | 2.61 | 2.95 | 2.97 | 2.22 | 0.49 times |
| 31 Wed Jul 2024 | 2.94 | 2.33 | 3.67 | 2.01 | 0.887 times |
| 28 Fri Jun 2024 | 2.33 | 2.53 | 2.68 | 2.18 | 1.161 times |
| 31 Fri May 2024 | 2.50 | 2.78 | 3.65 | 2.31 | 1.407 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Allogene Therapeutics (ALLO)
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Allogene Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Allogene Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Allogene Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.49 and Allogene Therapeutics (ALLO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Allogene Therapeutics ( (ALLO) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Allogene Therapeutics stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Allogene Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Allogene Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Allogene Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Allogene Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.49 and Allogene Therapeutics (ALLO) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Allogene Therapeutics (ALLO) stock. Volume based technical analysis of Allogene Therapeutics (ALLO) stock is negative.
Allogene Therapeutics Stock is giving positive returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.